Youssef Amin

Dr. Youssef Amin

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2025 in Advanced Materials Technologies
Verified
Journal Article
Open access
FBFaten Bashar
Faten Bashar
HFHouxin Fan
Houxin Fan
ZLZhenchao Liu
Zhenchao Liu
PDPaolo Donati
Paolo Donati
YAYoussef Amin
Youssef Amin
SHSailing He
Sailing He
In today's technologically advanced era, the demand for swift and precise analyses spans scientific research and industrial applications alike. Surface plasmon resonance (SPR) technology has surged in popularity, due to its real‐time measurement capabilities with exceptional sensitivity and label‐free operation. These attributes have propelled SPR into prominence across diverse fields including medical diagnostics, pharmaceuticals, food safety, and environmental monitoring of hazardous compounds. Here the key principles behind SPR are delved, and the workings of SPR‐based sensors are elucidated. Additionally, the latest advancements in SPR biosensors tailored for detecting a variety of analytes, with a focus on dopamine (DA) and α‐synuclein, which hold particular significance in the context of neurological disorders, are examined. Here potential breakthroughs of SPR technology are discussed, thanks to the integration with nanomaterials, lab‐on‐a‐chip devices, multiplexing formats, and machine learning. Finally, new resonance modes are discussed based on subwavelength structures leveraging guided mode resonance (GMR), surface lattice resonance (SLR), and bound state in the continuum (BIC) mode resonance and their potential applications, particularly in nonplasmonic refractive index biosensors.

2 July 2025 in Biosensors
Verified
Journal Article
Open access
PDF file
YAYoussef Amin
Youssef Amin
Paola CecerePaola Cecere
Paola Cecere
Pier Paolo PompaPier Paolo Pompa
Pier Paolo Pompa
Salivary α-amylase (sAA) is a widely recognized biomarker for stress and autonomic nervous system activity. However, conventional enzymatic assays used to quantify sAA are limited by time-consuming, lab-based protocols. In this study, we present a portable, AI-driven point-of-care system for automated sAA classification via colorimetric image analysis. The system integrates SCHEDA, a custom-designed imaging device providing and ensuring standardized illumination, with a deep learning pipeline optimized for mobile deployment. Two classification strategies were compared: (1) a modular YOLOv4-CNN architecture and (2) a unified YOLOv8 segmentation-classification model. The models were trained on a dataset of 1024 images representing an eight-class classification problem corresponding to distinct sAA concentrations. The results show that red-channel input significantly enhances YOLOv4-CNN performance, achieving 93.5% accuracy compared to 88% with full RGB images. The YOLOv8 model further outperformed both approaches, reaching 96.5% accuracy while simplifying the pipeline and enabling real-time, on-device inference. The system was deployed and validated on a smartphone, demonstrating consistent results in live tests. This work highlights a robust, low-cost platform capable of delivering fast, reliable, and scalable salivary diagnostics for mobile health applications.